Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 229-764-5 | CAS number: 6712-98-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 3 Feb to 12 March 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline study, to GLP, with slight deviations which are not expected to affect the outcome
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- temperature slightly outside of recommended range
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- temperature slightly outside of recommended range
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- An in vivo skin sensitisation study by the LLNA method does not need to be conducted because adequate data from a guinea pig maximisation test are available.
Test material
- Reference substance name:
- 1-(N,N-bis(2-hydroxyethyl)amino)propan-2-ol
- EC Number:
- 229-764-5
- EC Name:
- 1-(N,N-bis(2-hydroxyethyl)amino)propan-2-ol
- Cas Number:
- 6712-98-7
- Molecular formula:
- C7H17NO3
- IUPAC Name:
- 1-[bis(2-hydroxyethyl)amino]propan-2-ol
- Test material form:
- other: Viscous, clear colourless liquid
- Details on test material:
- - Name of test material (as cited in study report): Diethanolisopropanolamine (DEIPA)
- Substance type: Technical product
- Physical state: Liquid
- Analytical purity: 93%
- Impurities (identity and concentrations): No data
- Composition of test material, percentage of components: No data
- Isomers composition: No data
- Purity test date: Not specified
- Lot/batch No.: 980035B
- Expiration date of the lot/batch: Not specified
- Stability under test conditions: Not specified
- Storage condition of test material: Room temperature
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Crl:(HA)BR
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Portage Michigan
- Age at study initiation: 5 to 8 weeks
- Weight at study initiation: 372 to 574 g
- Housing: Individually housed in suspended stainless steel cages
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: At least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 26 [OECD guideline recommends 20 +/- 3, but unlikely to affect the outcome]
- Humidity (%): 30-70
- Air changes (per hr): Not specified
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 3 Feb 1999 To: 12 March 1999
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: Freund's Complete Adjuvant (FCA) and sterile water for intradermal injections, no vehicle for topical applications
- Concentration / amount:
- 1% w/v for intradermal injections
Undiluted (100%) for topical induction and challenge applications
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Freund's Complete Adjuvant (FCA) and sterile water for intradermal injections, no vehicle for topical applications
- Concentration / amount:
- 1% w/v for intradermal injections
Undiluted (100%) for topical induction and challenge applications
- No. of animals per dose:
- 20 males
- Details on study design:
- RANGE FINDING TESTS:
1st screening group: Four males treated intradermally, at a shaved site, with 0.1ml of DEIPA at 0.5, 1, 5 and 10% w/v in sterile water, each animal receiving all four concentrations. Injection sites evaluated for erythema and edema reactions at approx. 24-hours and 48-hours after injection.
2nd screening group: Four males received two 0.1ml intradermal injections of a 1:1 dilution of FCA and sterile water on the shoulder area. Twelve days after, all animals received a topical application of DEIPA at 1, 10, 25 and 50% w/v in sterile water covered with an occlusive patch. The patch was removed after 24 hours and the test site washed. Each animal received all four concentrations. Application sites were observed for dermal reactions at 24 and 48 hours after patch removal.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (Intradermal injections and topical application)
- Exposure period: Duplicate intradermal injections, 48-hour topical application
- Test groups: DEIPA in sterile water and FCA (1:1) injected, undiluted DEIPA for topical application
- Control group: FCA and sterile water
- Site: Midline over the shoulder region
- Frequency of applications: Intradermal injections administered on day 1, topical application on day 8.
- Duration: 0 to 8 days
- Concentrations: 1% w/v mixture in sterile water and FCA for the intradermal injection phase and undiluted for the topical application
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 22
- Exposure period: 24 hours
- Test groups: Undiluted DEIPA
- Control group: Undiluted DEIPA
- Site: Right and left side
- Concentrations: 100%
- Evaluation (hr after challenge): 24, 48 - Challenge controls:
- 10 males in control group, undiluted DEIPA used for challenge topical application
- Positive control substance(s):
- yes
- Remarks:
- hexylcinnamaldehyde
Results and discussion
- Positive control results:
- All 10 animals in the test group within this study exhibited mild to severe dermal reactions following challenge applications of undiluted HCA or a 50% mixture of HCA in mineral oil. None of the animals in the test group exhibited a dermal reaction to the vehicle at challenge. From these results, HCA is considered to be an extreme dermal sensitizer in guinea pigs by the maximization test. The positive control study was conducted within 6 months of the DEIPA sensitisation study.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.1 ml undiluted DEIPA
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- None reported
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.1 ml undiluted DEIPA. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: None reported.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.1 ml undiluted DEIPA
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- None reported
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.1 ml undiluted DEIPA. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: None reported.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- undiluted DEIPA
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- None reported
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- undiluted DEIPA
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- None reported
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 50% alpha-hexylcinnamaldehyde
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50% alpha-hexylcinnamaldehyde
- No. with + reactions:
- 5
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- undiluted alpha-hexylcinnamaldehyde
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- undiluted alpha-hexylcinnamaldehyde
- No. with + reactions:
- 7
- Total no. in group:
- 10
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In a GLP study, conducted according to OECD guideline 406, DEIPA was determined to be non-sensitising in the guinea pig maximisation test.
- Executive summary:
In a GLP study, conducted according to OECD guideline 406, the dermal sensitising potential of DEIPA was assessed in a guinea pig maximisation test. Following the initial screening phase, 20 animals were assigned to the test group and 10 to the control group. On day 1, animals in the test group received duplicate 0.1 ml intradermal injections either side of the midline over the shoulder region, of a 1:1 dilution of Freund’s Complete Adjuvant (FCA) in sterile water, 1% w/v suspension of test material in sterile water and 1% w/v suspension of test material in sterile water in FCA. Concurrently, the control group received duplicate 0.1 ml injections of a 1:1 dilution of FCA in sterile water, sterile water alone and a 1:1 dilution of sterile water in FCA. On day 7, the animals in both groups were pre-treated with 10% w/w sodium lauryl sulphate in petrolatum applied topically at the injection sites. One day later, undiluted test material or vehicle (sterile water) was applied topically over the injection sites to animals in the test and control group respectively, and covered with an occlusive dressing for 48 hours before removal of the material with a damp cloth.
All animals received a challenge dose 2 weeks after the topical application. The undiluted test material and vehicle were applied to the right and left side of the animal and covered with an occlusive dressing for 24 hours before removal with a damp cloth. The challenge sites were examined for dermal reaction at 24 and 48 hours following patch removal.
None of the animals in either the test or control group exhibited a dermal reaction to the challenge application of the test or control substances. There were no significant changes in body weights or treatment-related clinical signs of toxicity reported.
In this study, DEIPA can be considered as non-sensitising to the skin of guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
